News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Degussa Spinout Elbion AG Draws EUR25M Series A Round


10/19/2005 5:12:27 PM

Elbion AG reeled in €25 million in Germany's first significant biotech financing of 2005. The company, which was formed through a management buyout of some of Degussa AG's pharmaceutical assets in 2002, concentrates on the discovery and development of small molecules that are effective against inflammatory and central nervous system diseases.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES